Is Oxaliplatin Injection in shortage?
Oxaliplatin Injection is listed by FDA as being discontinued by at least one maker (updated Jun 29, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10)
Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
Maker contact: Sagent Pharmaceuticals: 866-625-1618
- Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20)
Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
Maker contact: Sagent Pharmaceuticals: 866-625-1618
- Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 847-550-2300
- Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 847-550-2300
- Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)
Discontinuation of the manufacture of the drug
Maker contact: 800-525-8747
- Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80)
Discontinuation of the manufacture of the drug
Maker contact: 800-525-8747
Oxaliplatin Injection shortage questions
Is Oxaliplatin Injection in shortage?
Oxaliplatin Injection is listed by FDA as being discontinued by at least one maker (updated Jun 29, 2026).
What should I do if I can’t get Oxaliplatin Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.